Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-11

Clinical Trial Update: Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating a two-step radioimmunotherapy approach for medullary thyroid carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantes University Hospital | Conditions: Thyroid Neoplasms | Phase 2 | Status: COMPLETED